Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibiotic prescribing for aspiration pneumonia in the intensive care unit.

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada·2026
Same author

Antimicrobial Resistance (AMR) Consequences of the use of Doxycycline for Prevention of Bacterial Sexually Transmitted Infections (STIs): A Systematic Review.

Sexually transmitted diseases·2026
Same author

Use of administrative data for evaluating trends in medically-attended Lyme disease, Manitoba, Canada, 2010-2021.

PloS one·2026
Same author

Populations at Risk for Severe or Complicated Rhinovirus Illness: A Systematic Review and Meta-Analysis.

Influenza and other respiratory viruses·2026
Same author

Antibiotic Prophylaxis Strategies and Surgical Site Infections in Colorectal Surgery: A Systematic Review and Network Meta-Analysis.

JAMA network open·2026
Same author

Macrolides for asthma: A systematic review and meta-analysis of randomized trials.

The Journal of allergy and clinical immunology·2026
Same journal

Rheumatoid arthritis: previously untreated early disease.

BMJ clinical evidence·2016
Same journal

Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.

BMJ clinical evidence·2016
Same journal

Subarachnoid haemorrhage (spontaneous aneurysmal).

BMJ clinical evidence·2016
Same journal

Malaria: fluid therapy in severe disease.

BMJ clinical evidence·2016
Same journal

Age-related macular degeneration: anti-vascular endothelial growth factor treatment.

BMJ clinical evidence·2016
Same journal

MRSA: treating people with infection.

BMJ clinical evidence·2016
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Community-acquired pneumonia.

Mark Loeb1

  • 1Departments of Pathology & Molecular Medicine and Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Canada.

BMJ Clinical Evidence
|March 23, 2011
PubMed
Summary
This summary is machine-generated.

This systematic review examines community-acquired pneumonia interventions, including antibiotics and vaccines. Evidence supports antibiotics and vaccines for preventing and treating pneumonia, with prompt administration crucial in intensive care.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Experiment Videos

Last Updated: Jun 3, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Background:

  • Community-acquired pneumonia affects approximately 12 per 1000 people annually in the Northern Hemisphere.
  • Streptococcus pneumoniae is a primary causative agent, with mortality rates varying from 5% to 35% based on disease severity.
  • Risk factors for worse outcomes include older age, male sex, and pre-existing chronic conditions.

Purpose of the Study:

  • To systematically review the effectiveness of interventions for preventing community-acquired pneumonia.
  • To evaluate treatments for community-acquired pneumonia across outpatient, inpatient, and intensive care settings.
  • To assess the safety and efficacy of various pneumonia interventions.

Main Methods:

  • Conducted a systematic review of literature up to January 2010.
  • Searched major databases including Medline, Embase, and The Cochrane Library.
  • Included data from systematic reviews, randomized controlled trials (RCTs), observational studies, and regulatory agency alerts.

Main Results:

  • Fifteen systematic reviews, RCTs, or observational studies met the inclusion criteria.
  • A GRADE evaluation was performed to assess the quality of evidence for interventions.
  • Data on antibiotic efficacy, vaccine effectiveness, and early mobilization were analyzed.

Conclusions:

  • The review presents evidence on the effectiveness and safety of key interventions for community-acquired pneumonia.
  • Interventions evaluated include antibiotics (oral, intravenous), influenza vaccine, and pneumococcal vaccine.
  • Prompt antibiotic administration in intensive care settings and early mobilization are highlighted.